These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 27520584)

  • 41. Telomere length in Hepatitis C.
    Kitay-Cohen Y; Goldberg-Bittman L; Hadary R; Fejgin MD; Amiel A
    Cancer Genet Cytogenet; 2008 Nov; 187(1):34-8. PubMed ID: 18992639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver transplantation of patients with cryptogenic cirrhosis: clinical characteristics and outcome.
    Marmur J; Bergquist A; Stål P
    Scand J Gastroenterol; 2010; 45(1):60-9. PubMed ID: 20030578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric analysis of fluorescence in situ hybridization with dye dilution and DNA staining (flow-FISH-DDD) to determine telomere length dynamics in proliferating cells.
    Potter AJ; Wener MH
    Cytometry A; 2005 Nov; 68(1):53-8. PubMed ID: 16163702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Wong CR; Nguyen MH; Lim JK
    World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Replication timing of human telomeric DNA and other repetitive sequences analyzed by fluorescence in situ hybridization and flow cytometry.
    Hultdin M; Grönlund E; Norrback KF; Just T; Taneja K; Roos G
    Exp Cell Res; 2001 Dec; 271(2):223-9. PubMed ID: 11716534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Whole chromosome loss is promoted by telomere dysfunction in primary cells.
    Pampalona J; Soler D; Genescà A; Tusell L
    Genes Chromosomes Cancer; 2010 Apr; 49(4):368-78. PubMed ID: 20088004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidy.
    Leach NT; Rehder C; Jensen K; Holt S; Jackson-Cook C
    Mech Ageing Dev; 2004 Aug; 125(8):563-73. PubMed ID: 15336914
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
    Sun C; Fan JG; Qiao L
    Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Telomere length in human blastocysts.
    Mania A; Mantzouratou A; Delhanty JD; Baio G; Serhal P; Sengupta SB
    Reprod Biomed Online; 2014 May; 28(5):624-37. PubMed ID: 24581987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution.
    Tana C; Tana M; Rossi S; Silingardi M; Schiavone C
    J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Large liver cell change in hepatitis B virus-related liver cirrhosis.
    Kim H; Oh BK; Roncalli M; Park C; Yoon SM; Yoo JE; Park YN
    Hepatology; 2009 Sep; 50(3):752-62. PubMed ID: 19585549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between Telomere Maintenance and Liver Disease.
    Barnard A; Moch A; Saab S
    Gut Liver; 2019 Jan; 13(1):11-15. PubMed ID: 30400735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Replication status as a possible marker for genomic instability in cells originating from genotypes with balanced rearrangements.
    Amiel A; Levi E; Reish O; Sharony R; Fejgin MD
    Chromosome Res; 2001; 9(8):611-6. PubMed ID: 11778683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Replication Timing Aberration of
    Ayala FRR; Martin JW; Bertuzzo CS
    Glob Med Genet; 2023 Jun; 10(2):54-62. PubMed ID: 37091312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The telomere hypothesis for progressive liver cirrhosis.
    Murphy F; Iredale J
    J Hepatol; 2003 Mar; 38(3):378-9. PubMed ID: 12586310
    [No Abstract]   [Full Text] [Related]  

  • 59. [Fatty liver disease and DNA replication stress].
    Donné R; Desdouets C
    Med Sci (Paris); 2024 Mar; 40(3):231-234. PubMed ID: 38520094
    [No Abstract]   [Full Text] [Related]  

  • 60. Chromosomal Rearrangements and Altered Nuclear Organization: Recent Mechanistic Models in Cancer.
    Federico C; Bruno F; Ragusa D; Clements CS; Brancato D; Henry MP; Bridger JM; Tosi S; Saccone S
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.